SCHEMBL31028705

SCHEMBL31028705

NS(=O)(=O)c1cccnc1C(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.53
CA1 P00915 9/20 0.53
CA9 Q16790 7/20 0.53
MAPK1 P28482 1/20 0.53
FTO Q9C0B1 1/20 0.45
LMNA P02545 3/20 0.44
TRPV4 Q9HBA0 1/20 0.44
AR P10275 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
CA12 O43570 5/20 0.41
CA6 P23280 3/20 0.41
CA4 P22748 2/20 0.41
CA5A P35218 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27801399 0.87 CA1 (0.49) CA2CA1CA9MAPK1FTO
SCHEMBL578800 0.85 CA1 (0.53) CA2CA1CA9MAPK1FTO
SCHEMBL579298 0.82 CA1 (0.47) CA2CA1CA9MAPK1FTO
SCHEMBL27713085 0.82 CA1 (0.44) CA2CA1CA9MAPK1FTO
SCHEMBL3717781 0.80 CA2 (0.45) CA2CA1CA9MAPK1FTO
SCHEMBL578867 0.80 CA2 (0.45) CA2CA1CA9MAPK1FTO
SCHEMBL3717326 0.80 CA2 (0.45) CA2CA1CA9MAPK1FTO
SCHEMBL27857902 0.79 CA1 (0.47) CA2CA1CA9MAPK1FTO
SCHEMBL8510750 0.76 LMNA (0.42) CA2CA1CA9MAPK1FTO
SCHEMBL20502571 0.76 CA1 (0.56) CA2CA1CA9MAPK1FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO disclosed